BTIG Rates Henry Schein (HSIC) buy, $100 Price Target

BTIG analyst David Larsen raises the price target for Henry Schein, Inc. to $100 from $100, maintaining a buy rating, a 23.32% upside from the current price.

By TradeTexts Research Desk · Published Jun 12, 2026, 9:14 PM EDT · Updated Jun 16, 2026, 9:02 AM EDT

Reviewed by automated data checks against the source data. How we make and check alerts

BTIG rated Henry Schein, Inc. ($HSIC) "buy" with a $100 price target on June 11, 2026.

Since the rating, $HSIC is down 0.4% after 1 week, up 6.9% after 1 month and up 7.7% to date (from the $80.22 close on Jun 11, 2026).

HSIC Henry Schein, Inc.

$86.38 +12.44% year to date

Daily close · Oct 16, 2026

Key Points

BTIG analyst David Larsen raised the price target for Henry Schein, Inc. (HSIC) to $100 while maintaining a buy rating. The stock is currently trading at $81.09.
BTIG's $100 price target implies 23.32% upside from Henry Schein, Inc.'s ($HSIC) current $81.09 share price.
Henry Schein has a market cap of about $9.5 billion and a P/E ratio of 24.8, indicating solid earnings relative to its stock price.
The average target price from analysts for Henry Schein now stands at approximately $98.19, with 16 firms offering their opinions.

Get $HSIC trade alerts by text

We text you when insiders, Congress or big funds trade $HSIC. Free.

Not investment advice. TradeTexts is not a registered investment adviser, and this automated Henry Schein, Inc. alert may contain errors. Disclosures

BTIG Updates Price Target

BTIG has increased its price target for Henry Schein, Inc. (HSIC) to $100, up from a previous target of $100. Analyst David Larsen maintains a buy rating on the stock, which is currently trading at $81.09, as of the last published close. This change reflects the firm's positive outlook on the company's performance ahead.

Analysts Set New Price Targets

Other analysts have also shared their views on Henry Schein. Leerink Partners recently maintained a Market Perform rating with a target of $92.00, down from $96.00 on October 14, 2026. Barclays holds an Overweight rating with a price target of $100.00, increased from $86.00 on August 6, 2026. Citigroup maintains a Buy rating with a price target of $112.00, up from $100.00, also issued on August 5, 2026.

How Henry Schein, Inc. Stock Has Traded

Henry Schein's stock is currently trading below its 52-week high of $92.18, which suggests potential upside given the new price target. The stock's performance is significant as it trades above its 50-day moving average of $87.88, indicating some positive momentum.

12-month forecast

$HSIC price target

Henry Schein, Inc. daily closes and this analyst's $100 target. Not advice.

What Henry Schein, Inc. Does

Henry Schein, Inc. provides healthcare products and services to dental and medical offices globally. With a robust product range, including infection-control items and practice management software, it serves various healthcare sectors. The firm's recent analyst attention reflects confidence in its growth prospects.

What’s Next for Henry Schein

Henry Schein is set to report its next earnings on November 3, 2026. Investors will be keeping an eye on these results to gauge the company’s performance and whether it can meet or exceed the raised analyst expectations.